These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Spatial training and high-frequency stimulation engage a common pathway to enhance glutamate release in the hippocampus. Richter-Levin G; Canevari L; Bliss TV Learn Mem; 1998; 4(6):445-50. PubMed ID: 10701870 [TBL] [Abstract][Full Text] [Related]
6. Activation of neuropeptide Y Y1 receptors inhibits glutamate release through reduction of voltage-dependent Ca2+ entry in the rat cerebral cortex nerve terminals: suppression of this inhibitory effect by the protein kinase C-dependent facilitatory pathway. Wang SJ Neuroscience; 2005; 134(3):987-1000. PubMed ID: 16026936 [TBL] [Abstract][Full Text] [Related]
7. Long-term potentiation in the dentate gyrus of the anaesthetized rat is accompanied by an increase in extracellular glutamate: real-time measurements using a novel dialysis electrode. Errington ML; Galley PT; Bliss TV Philos Trans R Soc Lond B Biol Sci; 2003 Apr; 358(1432):675-87. PubMed ID: 12740113 [TBL] [Abstract][Full Text] [Related]
8. NMDA receptor activation induces glutamate release through nitric oxide synthesis in guinea pig dentate gyrus. Nei K; Matsuyama S; Shuntoh H; Tanaka C Brain Res; 1996 Jul; 728(1):105-10. PubMed ID: 8864303 [TBL] [Abstract][Full Text] [Related]
9. LTP occludes the interaction between arachidonic acid and ACPD and NGF and ACPD. Kelly A; Lynch MA Neuroreport; 1998 Dec; 9(18):4087-91. PubMed ID: 9926852 [TBL] [Abstract][Full Text] [Related]
10. The effect of the desglycinyl metabolite of remacemide hydrochloride (FPL 12495AA) and dizocilpine (MK-801) on endogenous amino acid release from mouse cortex. Srinivasan J; Richens A; Davies JA Br J Pharmacol; 1995 Dec; 116(8):3087-92. PubMed ID: 8719781 [TBL] [Abstract][Full Text] [Related]
11. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo. Gilbert ME; Lasley SM Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801 [TBL] [Abstract][Full Text] [Related]
12. Dimebon, an antihistamine drug, inhibits glutamate release in rat cerebrocortical nerve terminals. Wang CC; Kuo JR; Wang SJ Eur J Pharmacol; 2014 Jul; 734():67-76. PubMed ID: 24726847 [TBL] [Abstract][Full Text] [Related]
13. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective. Priestley T; Marshall GR; Hill RG; Kemp JA Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395 [TBL] [Abstract][Full Text] [Related]
14. Presynaptic glutamatergic function in dentate gyrus in vivo is diminished by chronic exposure to inorganic lead. Lasley SM; Gilbert ME Brain Res; 1996 Oct; 736(1-2):125-34. PubMed ID: 8930317 [TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus. Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992 [TBL] [Abstract][Full Text] [Related]
16. Depolarization and synaptosomal glutamine utilization. Sherman AD Neurochem Res; 1991 Apr; 16(4):501-4. PubMed ID: 1922661 [TBL] [Abstract][Full Text] [Related]
17. GABAergic modulation of hippocampal glutamatergic neurons: an in vivo microdialysis study. Tanaka S; Tsuchida A; Kiuchi Y; Oguchi K; Numazawa S; Yoshida T Eur J Pharmacol; 2003 Mar; 465(1-2):61-7. PubMed ID: 12650834 [TBL] [Abstract][Full Text] [Related]
18. Simultaneous action of MK-801 (dizclopine) on dopamine, glutamate, aspartate and GABA release from striatum isolated nerve endings. Sitges M; Nekrassov V; Guarneros A Brain Res; 2000 Jan; 854(1-2):48-56. PubMed ID: 10784106 [TBL] [Abstract][Full Text] [Related]